| Literature DB >> 31885546 |
Alessandro Agostini1, Eleonora Scaioli2, Andrea Belluzzi2, Massimo Campieri2.
Abstract
BACKGROUND: Inflammatory bowel diseases (IBD) are associated with stress, poor quality of life, and attachment insecurity. Mentalization is the human ability to perceive and reason about feelings and psychological dispositions of one's self and others. The chronic disorders are believed to affect patients' mentalizing abilities and to determine a shift towards attachment insecurity in patients affected. In this study, the attachment dimensions and mentalization were assessed in IBD patients and healthy controls. Further knowledge about the interplay among IBD, mentalization, and attachment might shed more light into the psychopathological mechanisms leading to insecurity and vulnerability to stress in IBD.Entities:
Year: 2019 PMID: 31885546 PMCID: PMC6915150 DOI: 10.1155/2019/7847123
Source DB: PubMed Journal: Gastroenterol Res Pract ISSN: 1687-6121 Impact factor: 2.260
Figure 1Example of one of the 36 photos of the Eyes test.
Sociodemographic and clinical characteristics of the two study groups. Values denote mean (±standard deviation) or numbers of subjects.
| IBD patients | Healthy controls |
| |
|---|---|---|---|
| Sociodemographics | |||
| Age | 39.64 (±14.06) | 36.30 (±12.29) | n.s. |
| Sex | 48 female, 48 male | 50 female, 52 male | n.s. |
| Education (years) | 13.41 (±3.09) | 14.07 (±2.12) | n.s. |
| Clinical characteristics | |||
| Disease | 64 CD, 32 UC | ||
| Disease duration (years) | 12.39 (±11.44) | ||
| Age at diagnosis (years) | 27.56 (±12.09) | ||
| Disease activity (CDAI and PMS) | 55 remission | ||
| 22 mild activity | |||
| 19 moderate activity | |||
| Therapy | 19 no treatments | ||
| 29 5-ASA | |||
| 3 azathioprine | |||
| 5 corticosteroids | |||
| 40 biologic agents | |||
| Surgery | 75 never treated | ||
| 21 previously treated | |||
| Psychometric measures | |||
| Eyes test | 22.21 (±4.38) | 24.37 (±3.17) | <.001 |
| Male 21.93 (±4.63) | |||
| Female 22.48 (±4.14) | n.s. | ||
| Male 23.47 (±3.59) | |||
| Female 25.15 (±2.55) | .012 | ||
| ASQ Confidence | 30.46 (±5.52) | 31.97 (±4.37) | n.s. |
| ASQ Discomfort with closeness | 35.92 (±6.64) | 34.76 (±5.47) | n.s. |
| ASQ Relationships as secondary | 15.30 (±6.65) | 15.22 (±4.97) | n.s. |
| ASQ Need for approval | 20.73 (±5.98) | 20.68 (±5.11) | n.s. |
| ASQ Preoccupation with relationships | 28.76 (±6.65) | 26.73 (±5.18) | .034 |
| RFQ certainty | 1.12 (±.99) | .99 (±.63) | n.s. |
| RFQ uncertainty | .72 (±.62) | .59 (±.49) | n.s. |
Correlation analyses in the healthy control group.
| RFQ certainty | RFQ uncertainty | ASQ Confidence | ASQ Discomfort with closeness | ASQ Relationships as secondary | ASQ Need for approval | ASQ Preoccupation with relationships | |
|---|---|---|---|---|---|---|---|
| Eyes test | .056 | .02 | .76 | -.019 | -.12 | .15 | .01 |
| RFQ certainty | -.566∗∗∗ | .092 | -.275∗∗ | -.043 | -.234∗ | -.377∗∗∗ | |
| RFQ uncertainty | -.167 | .159 | .117 | .252∗ | .300∗∗ | ||
| ASQ Confidence | -.284∗∗ | -.114 | -.180 | -.071 | |||
| ASQ Discomfort with closeness | .454∗∗∗ | .332∗∗ | .336∗∗∗ | ||||
| ASQ Relationships as secondary | .246 | .202∗ | |||||
| ASQ Need for approval | .512∗∗∗ |
∗ p < .05; ∗∗p < .01; ∗∗∗p < .001. RFQ = reflective functioning questionnaire; ASQ = attachment style questionnaire.
Correlation analyses in the IBD patient group.
| RFQ certainty | RFQ uncertainty | ASQ Confidence | ASQ Discomfort with closeness | ASQ Relationships as secondary | ASQ Need for approval | ASQ Preoccupation with relationships | Disease activity | Disease duration | |
|---|---|---|---|---|---|---|---|---|---|
| Eyes test | .056 | -.049 | -.163 | .007 | -.295∗∗ | -.045 | -.074 | -.327∗∗ | -.083 |
| RFQ certainty | -.478∗∗∗ | .120 | -.058 | .004 | -.195 | -.137 | .067 | .062 | |
| RFQ uncertainty | .020 | .021 | .012 | .243∗ | .267∗∗ | .023 | -.037 | ||
| ASQ Confidence | -.182 | -.043 | -.098 | -.214∗ | .149 | .078 | |||
| ASQ Discomfort with closeness | .295∗∗ | .417∗∗ | .244∗ | -.017 | -.030 | ||||
| ASQ Relationships as secondary | .356∗∗∗ | .137 | .077 | .154 | |||||
| ASQ Need for approval | .518∗∗∗ | -.203 | -.020 | ||||||
| ASQ Preoccupation with relationships | -.113 | -.217∗ |
∗ p < .05; ∗∗p < .01; ∗∗∗p < .001. IBD = inflammatory bowel disease; RFQ = reflective functioning questionnaire; ASQ = attachment style questionnaire. The disease activity was measured using Crohn's disease activity index (CDAI) for CD and the Partial Mayo Score (PMS) for UC.
Figure 2